Medicine and Dentistry
Biological Marker
21%
Biopsy Technique
13%
Breast Cancer
73%
Breast Carcinoma
17%
Cancer Cell
14%
Cancer Staging
9%
Carcinoma
21%
Carisoprodol
9%
Cell Proliferation
11%
Chemotherapy
18%
Colon Carcinoma
10%
Colorectal Carcinoma
21%
Cyclooxygenase 2
19%
Disease
10%
ELAV Like Protein 1
13%
Endometriosis
18%
Endometrium
10%
Endometrium Carcinoma
21%
Epidermal Growth Factor Receptor
9%
Epidermal Growth Factor Receptor 2
16%
Estrogen Receptor
16%
Formaldehyde
16%
Gamma Urogastrone
15%
Guanine Nucleotide Binding Protein
9%
Hazard Ratio
22%
Histone Deacetylase
13%
Hormone Receptor
14%
Immunohistochemistry
32%
In Situ Hybridization
12%
In Vitro
27%
Krukenberg Tumor
100%
Lymph Node
10%
Malignant Neoplasm
19%
Mammalian Target of Rapamycin
9%
Melanoma
13%
Messenger RNA
31%
Metastatic Carcinoma
15%
Neoplasm
83%
Next Generation Sequencing
10%
Ovarian Cancer
49%
Overall Survival
19%
Pathologist
10%
Primary Tumor
9%
Prognostic Factor
30%
Protein Expression
24%
Protein P53
11%
Receptor Expression
12%
Risk Stratification
9%
Tissue Microarray
9%
Uterine Cancer
30%
Keyphrases
Anthracyclines
11%
Breast Cancer
58%
Breast Cancer Patients
10%
Carcinoma
22%
Colorectal Cancer
15%
Core Needle Biopsy
16%
Cyclooxygenase-2
27%
Cyclooxygenase-2 Expression
12%
Distinct Subtypes
10%
DNA Methylation (DNAm)
13%
Endometrial Cancer
29%
Endometriosis
22%
EndoPredict
18%
Epithelial Ovarian Cancer
28%
Expression Pattern
22%
Formalin-fixed Paraffin-embedded Tissue
19%
GPER1
13%
Hazard Ratio
18%
HER2 Status
11%
High Risk
11%
Histone Deacetylase 1 (HDAC1)
12%
Hormone Receptor-positive
14%
Human Epidermal Growth Factor Receptor 2 (HER2)
29%
Human Ovarian Carcinoma
15%
Immunohistochemistry
33%
In Situ Hybridization
16%
Mammalian Target of Rapamycin (mTOR)
13%
Metastasis
13%
MRNA Expression
15%
MRNA Level
14%
Ovarian Cancer
32%
Ovarian Cancer Cells
17%
Ovarian Carcinoma
48%
Overall Survival
26%
Overexpression
24%
P53 Expression
11%
PITX2
13%
Polo-like Kinase 1 (PLK1)
18%
Poor Prognosis
10%
Prognostic Factors
25%
Prognostic Impact
30%
Programmed Death-ligand 1 (PD-L1)
18%
Protein Expression
22%
Quantitative PCR
12%
Sporadic Colorectal Cancer
13%
Tissue Microarray
10%
Triple-negative Breast Cancer
26%
Tumor
36%
Tumor Grade
14%
Tumor-infiltrating Lymphocytes
12%
